GlassScriptPhysician profile
Roja Rani Mulamalla
NPI 1396869681
$1,118.41
in general payments reported to CMS, 2019-2025
18 companies · $45.73 in 2025
The $45.73 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $49.94 · 2021: $142 · 2022: $291 · 2023: $197 · 2024: $115 · 2025: $45.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $289.46 | 2019-2025 | Watchman Access System, Farapulse, Watchman Flx |
| Medtronic, INC. | $189.29 | 2021-2023 | Onyx Frontier, Venaseal |
| Abbott Laboratories | $90.19 | 2019-2025 | Mitraclip, Triclip |
| Cvrx, INC. | $90.00 | 2021-2023 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $82.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $78.33 | 2022 | |
| Medtronic Vascular, INC. | $46.88 | 2019-2020 | |
| Baxter Healthcare | $43.75 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $39.59 | 2024 | Camzyos |
| Abiomed | $29.39 | 2024 | Impella |
| Lantheus Medical Imaging, INC. | $25.84 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.66 | 2023-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.20 | 2023 | Jardiance |
| Sanofi-Aventis U.S. LLC | $17.14 | 2019 | |
| Livanova USA, INC. | $15.63 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventice Services, LLC | $15.26 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.94 | 2019 | |
| Cardiovascular Systems INC. | $7.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roja Mulamalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.